October 6, 2023 by Rohin Pujari Skadden is advising POINT Biopharma on its $1.4 billion acquisition by Eli Lilly.
June 28, 2024 Navigating Cross-Border M&A: Insights Into Indonesia’s Legal Landscape. - Denny Rahmansyah - Partner,